Feverfew
Feverfew is a long-popular migraine preventive whose best trial produced a difference of only 0.6 attacks per month versus placebo, and whose older positive studies were tiny. Cochrane rates the evidence low quality — the honest summary is that feverfew probably does very little.
What the science says
- Migraine frequency Limited evidence
The 2015 Cochrane review covered six trials (561 patients) and could not pool them. The largest rigorous trial (n = 218, MIG-99 CO2 extract) reduced attacks from 4.8 to 2.9 per month versus 4.8 to 3.5 on placebo — a between-group difference of 0.6 attacks per month, rated low quality evidence.
- Earlier positive trials do not hold up Limited evidence
Three trials reporting clear benefit had only 17 to 60 participants each, while two more rigorous trials (n = 50 and n = 147) found no significant difference from placebo. This is the classic pattern of an effect that shrinks as study quality rises.
- Attack severity, duration and nausea Limited evidence
Across the included trials no statistically significant differences were found for migraine intensity or duration, incidence or severity of nausea and vomiting, or global assessment. Any benefit appears confined to attack count.
Dosage & safety
How to take it
Interactions
With medications
- warfarin, DOACs, aspirin and antiplatelet drugs
Parthenolide has antiplatelet activity in laboratory work and may add to bleeding risk. use caution, and stop before surgery
With other supplements
- fish oil, ginkgo and garlic
Additive antiplatelet effect. avoid stacking before a procedure
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does feverfew prevent migraines?
Feverfew probably does very little: the Cochrane review rated the evidence low quality, and the largest rigorous trial found only 0.6 fewer attacks per month than placebo. Earlier positive feverfew trials were tiny.
How much feverfew should I take for migraine?
The best-tested feverfew preparation is a CO2 extract at 6.25 mg three times daily; older trials used 50-143 mg/day of leaf standardised to at least 0.2% parthenolide. Allow 12 weeks, and note some products contain almost no parthenolide.
Can you stop feverfew suddenly?
Taper feverfew rather than stopping abruptly after months of use, or you risk 'post-feverfew syndrome': rebound headache, anxiety, insomnia and joint stiffness.
Who should avoid feverfew?
Avoid feverfew in pregnancy because of uterine stimulant activity, and if you are allergic to ragweed, chamomile or chrysanthemum. Feverfew's parthenolide has antiplatelet activity, so use caution with blood thinners and stop before surgery.
Scientific references
Where to buy
Nature's Answer, Feverfew Extract, Alcohol-Free, 1 fl oz (30 ml)
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Brain & cognition
- Vitamin B2 (Riboflavin) Moderate evidence
- Choline Moderate evidence
- Magnesium L-Threonate Limited evidence
- Phosphatidylserine Limited evidence
- Lecithin (Phosphatidylcholine) Limited evidence
- Agmatine Sulfate Limited evidence